These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18522749)

  • 1. Mammary carcinoma behavior is programmed in the precancer stem cell.
    Damonte P; Hodgson JG; Chen JQ; Young LJ; Cardiff RD; Borowsky AD
    Breast Cancer Res; 2008; 10(3):R50. PubMed ID: 18522749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.
    Maglione JE; McGoldrick ET; Young LJ; Namba R; Gregg JP; Liu L; Moghanaki D; Ellies LG; Borowsky AD; Cardiff RD; MacLeod CL
    Mol Cancer Ther; 2004 Aug; 3(8):941-53. PubMed ID: 15299077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of mammary lesions represent molecular differences.
    Namba R; Maglione JE; Davis RR; Baron CA; Liu S; Carmack CE; Young LJ; Borowsky AD; Cardiff RD; Gregg JP
    BMC Cancer; 2006 Dec; 6():275. PubMed ID: 17147824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose Uptake and Intracellular pH in a Mouse Model of Ductal Carcinoma In situ (DCIS) Suggests Metabolic Heterogeneity.
    Lobo RC; Hubbard NE; Damonte P; Mori H; Pénzváltó Z; Pham C; Koehne AL; Go AC; Anderson SE; Cala PM; Borowsky AD
    Front Cell Dev Biol; 2016; 4():93. PubMed ID: 27630987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and genetic properties of the p53 null preneoplastic mammary epithelium.
    Medina D; Kittrell FS; Shepard A; Stephens LC; Jiang C; Lu J; Allred DC; McCarthy M; Ullrich RL
    FASEB J; 2002 Jun; 16(8):881-3. PubMed ID: 11967232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation.
    Vafaizadeh V; Klemmt P; Brendel C; Weber K; Doebele C; Britt K; Grez M; Fehse B; Desriviéres S; Groner B
    Stem Cells; 2010 May; 28(5):928-38. PubMed ID: 20235097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro.
    Ozbun MA; Jerry DJ; Kittrell FS; Medina D; Butel JS
    Cancer Res; 1993 Apr; 53(7):1646-52. PubMed ID: 8453637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes.
    Bhagirath D; Zhao X; West WW; Qiu F; Band H; Band V
    Oncotarget; 2015 Apr; 6(11):9018-30. PubMed ID: 25940703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.
    Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE
    Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo.
    Medina D; Kittrell FS
    Carcinogenesis; 1993 Jan; 14(1):25-8. PubMed ID: 8425268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin.
    Hellmén E; Moller M; Blankenstein MA; Andersson L; Westermark B
    Breast Cancer Res Treat; 2000 Jun; 61(3):197-210. PubMed ID: 10965996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature.
    Ferletta M; Grawé J; Hellmén E
    Int J Dev Biol; 2011; 55(7-9):791-9. PubMed ID: 22161835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
    Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
    Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors.
    Wang Q; Ding H; Wang H; Li P; Liu B; Zhang K
    Oncol Rep; 2015 Jan; 33(1):179-84. PubMed ID: 25354531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model.
    Bumaschny V; Urtreger A; Diament M; Krasnapolski M; Fiszman G; Klein S; Joffé EB
    Breast Cancer Res; 2004; 6(2):R116-29. PubMed ID: 14979922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multipotent luminal mammary cancer stem cells model tumor heterogeneity.
    Bao L; Cardiff RD; Steinbach P; Messer KS; Ellies LG
    Breast Cancer Res; 2015 Oct; 17(1):137. PubMed ID: 26467658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irradiation of juvenile, but not adult, mammary gland increases stem cell self-renewal and estrogen receptor negative tumors.
    Tang J; Fernandez-Garcia I; Vijayakumar S; Martinez-Ruis H; Illa-Bochaca I; Nguyen DH; Mao JH; Costes SV; Barcellos-Hoff MH
    Stem Cells; 2014 Mar; 32(3):649-61. PubMed ID: 24038768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.